|
|
| (11) | Number of the document | C 1625209 |
| (68) | Number of the document | 1625209 |
| (21) | Application number for Supplementary Protection Certificate | PA 2016 028 |
| (22) | Date of filing the application | 2016-10-18 |
| (41) | Date of publication of the application | 2016-11-10 |
| Date of publication of SPC | 2018-03-26 | |
| (24) | Date of coming into effect of SPC | 2024-05-07 |
| (71) |
Biogen Hemophilia Inc.,
,
|
| (73) |
BIOVERATIV THERAPEUTICS INC.,
225 Second Avenue, MA 02451 Waltham,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (93) | EU/1/16/1098, 2016-05-12 |
| (94) | 2029-05-06 |
| (95) | Eftrenonakogas alfa |
| Request filed | SPC extension granted until | Request refused | |
| 2021-06-15 |
| Payment date | Validity (years) | Amount | |
| 2026-03-23 | 3 | 347.00 EUR |
| 2027-05-07 |
| SPC granted |